These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 30332659)
1. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis. Li LH; Ma CC; Zhang HF; Lian YJ Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659 [TBL] [Abstract][Full Text] [Related]
2. LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Aurangzeb S; Symmonds M; Knight RK; Kennett R; Wehner T; Irani SR Seizure; 2017 Aug; 50():14-17. PubMed ID: 28586706 [TBL] [Abstract][Full Text] [Related]
3. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis. Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y Front Neurol; 2020; 11():280. PubMed ID: 32431657 [No Abstract] [Full Text] [Related]
4. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis. Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866 [TBL] [Abstract][Full Text] [Related]
5. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519 [TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures. Li Z; Cui T; Shi W; Wang Q Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233 [TBL] [Abstract][Full Text] [Related]
7. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China. Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752 [TBL] [Abstract][Full Text] [Related]
8. Electroclinical features of seizures associated with autoimmune encephalitis. Steriade C; Moosa ANV; Hantus S; Prayson RA; Alexopoulos A; Rae-Grant A Seizure; 2018 Aug; 60():198-204. PubMed ID: 30031297 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis. Li Y; Song F; Liu W; Wang Y Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701 [TBL] [Abstract][Full Text] [Related]
10. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Navarro V; Kas A; Apartis E; Chami L; Rogemond V; Levy P; Psimaras D; Habert MO; Baulac M; Delattre JY; Honnorat J; Brain; 2016 Apr; 139(Pt 4):1079-93. PubMed ID: 26945884 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179 [TBL] [Abstract][Full Text] [Related]
13. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis]. Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994 [TBL] [Abstract][Full Text] [Related]
14. Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis. Li TR; Zhang YD; Wang Q; Shao XQ; Lv RJ CNS Neurosci Ther; 2021 Oct; 27(10):1173-1181. PubMed ID: 34291554 [TBL] [Abstract][Full Text] [Related]
15. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study. Zhang W; Wang X; Shao N; Ma R; Meng H Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347 [TBL] [Abstract][Full Text] [Related]
16. Clinical features of 28 cases of anti Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922 [TBL] [Abstract][Full Text] [Related]
17. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China. Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063 [TBL] [Abstract][Full Text] [Related]
18. Faciobrachial dystonic seizures expressed as epileptic spasms, followed by focal seizures in anti-LGI1 encephalitis: a video-polygraphic study. d'Orsi G; Martino T; Lalla A; Claudio MTD; Carapelle E; Avolio C Epileptic Disord; 2018 Dec; 20(6):525-529. PubMed ID: 30530418 [TBL] [Abstract][Full Text] [Related]
19. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Irani SR; Michell AW; Lang B; Pettingill P; Waters P; Johnson MR; Schott JM; Armstrong RJ; S Zagami A; Bleasel A; Somerville ER; Smith SM; Vincent A Ann Neurol; 2011 May; 69(5):892-900. PubMed ID: 21416487 [TBL] [Abstract][Full Text] [Related]
20. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis. Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]